Search Results for

Gabor Tigyi Receives Prestigious International Award for Research

|

During his 30 years at UTHSC, Hungarian-born Gábor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor and former chair of the Department of Physiology in the UTHSC College of Medicine, has traveled to his birth country many times. However, in December, the trip back was a milestone. He traveled to Budapest at the invitation of… Read More

Professor Gabor Tigyi, MD, PhD, Receives Honorary Doctorate from Semmelweis University in Budapest

|

Gabor J. Tigyi, MD, PhD, professor in the Department of Physiology in the College of Medicine at the University of Tennessee Health Science Center (UTHSC), has received an honorary doctorate from Semmelweis University in Budapest, Hungary. Dr. Tigyi, who was born in Hungary, is the Harriet Van Vleet Endowment Professor in the Department of Physiology… Read More

UTHSC’s Dr. Gabor Tigyi Receives Distinguished Professorship at National Taiwan University

|

As a result of a longtime, long-distance research collaboration, Gabor Tigyi, MD, PhD, professor of physiology in the College of Medicine at the University of Tennessee Health Science Center (UTHSC), has received a prestigious appointment at the premier research university in Taiwan. Dr. Tigyi, the new associate vice chancellor for Research and Industry Relations at… Read More

There currently is no antidote for radiation injury. But Gabor Tigyi, MD, PhD, a professor and chair of the Department of Physiology in the College of Medicine at the University of Tennessee Health Science Center (UTHSC), and his team have spent more than 15 years working on one. Dr. Tigyi’s research team has developed a… Read More

Professor Gabor Tigyi Receives $2.39 Million Grant for Drug Discovery Research

|

Gabor Tigyi, MD, PhD (back row, third from left) and his team. The threat of a nuclear accident, like the one at Fukushima, or the explosion of a nuclear device necessitates the development of radiation countermeasures that are safe and effective when applied 24 hours or later after a radiation injury. There are no such… Read More

Gabor Tigyi, MD, PhD, Harriet S. Van Vleet Chair in Oncology Research, professor and chair in the Department of Physiology at UTHSC, has received a grant totaling $1,497,646 from the National Cancer Institute.

Gabor J. Tigyi, MD, PhD, professor and chair of the Department of Physiology at UTHSC, has been awarded $2,321,862 to study preclinical development of a new drug that protects from radiation injury.

More results for News?
| , ,
UT Health Science Center researchers Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in Basic Oncology Research, Junming Yue, PhD, associate professor in the Department of Pathology, Sue Chin...
| , ,
For Immediate ReleaseJune 30, 2023  MEMPHIS—University of Tennessee System President Randy Boyd announced the recipients of the 2023 President’s Awards. The announcement was made during the annual UT Board of Trustees...
| , ,
The UT Health Science Center (UTHSC) has officially submitted its nominees to the UT System for the 2023 President’s Awards. Based on the BE ONE UT values, these awards are...
More results in Announcements?
In the Media Icon
Cells try to repair damage to their DNA after radiation exposure, says Gábor Tigyi at the University of Tennessee Health Science Center
New Scientist
In the Media Icon
UT Health Science Center researchers Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in Basic Oncology Research, Junming Yue, PhD, associate professor in the Department of Pathology, Sue Chin...
Science Magazine
In the Media Icon
UT Health Science Center researchers Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in Basic Oncology Research, Junming Yue, PhD, associate professor in the Department of Pathology, Sue Chin...
News Medical Net
In the Media Icon
Cancer immunotherapy is a form of cancer treatment that uses the body’s immune system to prevent, control, and eliminate cancer, and it’s become a popular method. But it often fails...
Memphis Business Journal
In the Media Icon
A UTHSC-led team has received $3.16 million from the National Cancer Institute to develop a drug that boosts the immune system response in cancer patients to destroy tumor cells. Gabor...
EurekAlert!
The Commercial Appeal
Scientists in Tennessee are developing a promising drug they desperately hope will never be used. It’s a treatment that could rescue people from gastrointestinal acute radiation syndrome. In blunt terms,...
The Commercial Appeal
WREG
The Tennessee Institute of Regenerative Medicine is doing cutting-edge work at the University of Tennessee Health Science Center, and their goal is to translate scientific discoveries into new therapies for...
WREG
In the Media Icon
Se trata de un fármaco desarrollado a partir de un compuesto natural que se produce en la sangre y que favorece la cicatrización, según explica el líder de esta investigación,...
El Pais
More results for In the Media?